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Summary 
Obesity is an important public health problem worldwide and is a major risk factor for a number 
of chronic diseases such as type 2 diabetes, adverse cardiovascular events and metabolic syndrome related 
features. Different treatments have been applied to tackle body fat accumulation and its associated clinical 
manifestations. Often, relevant weight loss is achieved during the first six months under different dietary 
treatments. From this point, a plateau is reached, and a gradual recovery of the lost weight may occur. 
Therefore, new research approaches are being investigated to assure weight maintenance.  
Pioneering investigations have reported that oxygen variations in organic systems may produce 
changes in body composition. Possible applications of intermittent hypoxia to promote health and in 
various pathophysiological states have been reported.  
The hypoxic stimulus in addition to diet and exercise can be an interesting approach to lose 
weight, by inducing higher basal noradrenalin levels and other metabolic changes whose mechanisms are 
still unclear. Indeed, hypoxic situations increase the diameter of arterioles, produce peripheral 
vasodilatation and decrease arterial blood pressure. Furthermore, hypoxic training increases the activity of 
glycolytic enzymes, enhancing the number of mitochondria and glucose transporter GLUT-4 levels as well 
as improving insulin sensitivity. Moreover, hypoxia increases blood serotonin, decreases leptin levels while 
appetite is suppressed. These observations allow considering the hypothesis that intermittent hypoxia 
induces fat loss and may ameliorate cardiovascular health, which might be of interest for the treatment of 
obesity. This new strategy may be useful and practical for clinical applications in obese patients.  
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1. Obesity: Prevalence, causes and complications 
Obesity is an important public health problem in most countries [63], which is characterized by 
an excess of body fat, when amounting values higher than 20% in men and 30% in adult women [20, 66]. 
The World Health Organization (2009) warns that there are over 400 million obese adults, and that the 
situation will worsen in the future. 
The main etiological factors causing excess body weight for height are assigned to overeating 
and low physical activity, which lead to a positive energy balance, and result in a body fat increase 
[91]. Furthermore, there are other causes such as the genetic component, the distribution of energy intake 
throughout the day, the dietary composition of macronutrients, sleep rest, endocrine disruptions or the 
individual ability to oxidize energy substrates [26, 70, 93]. Thus, obesity is a chronic multifactorial 
disease resulting from the interaction between genotype, environment and physical activity patterns [14, 
91, 95].  
  Obesity is considered one of the major risk factors in the onset of associated chronic diseases, 
such as hypercholesterolemia, type II diabetes (T2D), cardiovascular disorders and metabolic syndrome 
features [101]. On the other hand, the higher BMI and waist circumference are, the greater is the relative 
risk of comorbidities [118]. Indeed, obesity has become the second leading cause of premature and 
evitable death, just after tobacco [14, 49]. 
 
2. Treatments for obesity: diet, exercise, pharmacology and bariatric surgery 
Low-calorie diets, programmes of physical activity (typically aerobic) and behavioural therapy 
are common strategies to lose weight in the obese patient [121]. These type of interventions are often the 
first step in any therapeutic approach to treat obesity. In general, it should be tested at least for six months 
before considering the introduction of any other therapeutic strategy [79]. The needs and characteristics of 
a treatment against obesity will be determined regarding the estimated risk in the obese patient and 
according to clinical criteria for therapeutic intervention [53]. Additionally, there are interindividual 
differences in the response to different dietetic interventions or to physical exercise due to the genetic 
predisposition [90]. Thus, some attempts to set out differences depending on the genotype have been 
reported, although the information about the treatment success is relatively poor. 
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Other therapeutic approaches have been applied to induce weight loss, which may include 
exercise, psychological support, drug therapy and at last, surgery treatment [50], being the first two also 
prevention strategies. Therefore, long-term approaches to maintain weight loss are still sought. 
Generally speaking, weight losses are achieved during the first six months of treatment. From 
this point a plateau is often reached, and a gradual recovery of the lost weight commonly occurs [39]. 
This outcome is facilitated by the fact that adherence to the diet and physical activity often declines and 
also due to a possible metabolic adaptation [10], therefore long-lasting therapies are been searched. 
 
2.1 Dietetic and nutritional treatments 
  The most common treatment guidelines for obesity, currently in use, are dietary and nutritional 
approaches [1]. The restriction should not result in a caloric intake below 1.000-1.200 kcal / day 
in women and 1200-1600 kcal/day in men (except in case of morbid obesity), since that value is the 
minimum energy intake, which ensures a balanced intake of micronutrients in the requested amounts [10, 
2, 103]. An energy restriction of 500-1000 kcal/day compared to the usual diet results in weight loss of 
0.5-1.0 kg/week, which represents an average of 8-10% of initial body weight in 6 months [1]. However, 
this weight loss is not completely linear [8]. 
There is some controversy regarding the distribution of macronutrients to be prescribed, being 
the classical approach, with respect to a 1000-1600 kcal/day, a distribution of 20% proteins, 50% 
carbohydrates and 25-35% fat [48], although moderate high protein diets (30% energy) can also be 
applied [80]. Short-term weight reductions have been observed, but weight is regained in the long-term 
[5]. It seems that one of the causes for the interruption in weight loss is a reduction in basal energy 
expenditure [106]. Protein intake is maintained high in some cases with the aim of slowing the loss of 
lean body mass and delaying the stabilization of weight [1, 280]. However, there are several unresolved 
issues, such as the prescription of moderately high protein diets (20-35% of energy) during the weight 
maintenance phase or the beneficial effect of some foods with lower glycaemic index or glycaemic load 
on body weight [2, 80, 144]. Considering high-protein or low-fat diets, it is important to increase the 
amount of fibre (more than 30g/day) and the monounsaturated fat in order to facilitate the maintenance of 
a healthy circulating lipid profile [114]. In conclusion, one can notice that adherence is low in many of 
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the extreme diets, with different proportions of macronutrients, being the cause that in the long-term they 
are often not effective and obese people need other types of aid [39].  
 
2.2. Physical activity programmes 
  Some guidelines state that 60-90 daily minutes of moderate exercise are requested for the 
treatment of obesity [67]. Traditionally, aerobic exercise has been recommended in order to lose body 
fat, but recent studies show that strength-endurance exercises (circuits of 6-10 exercises and 10-15 reps, 
with a frequency of 2-3 times / week) can be more effective, particularly to reduce abdominal fat [60, 97] 
and visceral adipose tissue [62]. 
The strength-endurance programmes tend to burn primarily abdominal fat, unlike fasting 
[141]. They also favour low appetite by stimulating the corticotrophin-releasing hormone [115]. The 
most effective treatment to improve health parameters as well as body composition appears to be strength 
training or strength training combined with aerobic endurance training, which seem to improve both 
health biomarkers and to reduce fat content [135, 142, 145].  
Since the energy cost of all exercise modes except walking seems to be beneficial, priority 
should be given to the obese preferences to promote long-term activity behavioral change [137]. 
Moreover, it is known that physical exercise increases the secretion of endorphins [74], improving mood, 
and helping the patient to maintain motivation increasing adherence to the treatment.  
Strength-resistance training (SRT) is associated with great energy expenditure during the 
exercise session [30]. Some studies have reported that regular SRT is effective in promoting weight loss 
in obese subjects, decreasing fat mass and increasing lean body mass and thus has little influence or no 
effective change in total body weight [59, 120, 132]. SRT prevent the loss of lean body mass, secondary 
to dietary restriction [134] and reduces exercise-induced oxidative stress and homocysteine, regardless of 
adiposity [125]. A potential mechanism for this reduction could include contraction-induced antioxidant 
enzyme up-regulation [139]. 
Several studies have demonstrated a decrease in visceral adipose tissue after SRT programs [139, 
38] which seem to reduce visceral fat depots through both immediate effects (during weight loss and 
weight maintenance) and delayed effects (during weight regain). Furthermore, it has been shown that 
SRT preferentially mobilizes the visceral and subcutaneous adipose tissue in the abdominal region [31, 
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38, 61, 105]. This kind of training procedure improves insulin-stimulated glucose uptake in patients with 
impaired glucose tolerance or T2D [41]. Subsequent increases in muscle mass, may regulate glucose 
levels and insulin responses to glucose load and therefore, improves insulin sensitivity [22, 132]. Also, 
high-intensity SRT decrease glycosylated haemoglobin (HbA1c) levels in diabetics, regardless of age [13, 
127]. In addition, SRT is considered a potential coadjuvant to pharmacotherapy for the treatment of 
metabolic disorders, by decreasing some major risk factors of metabolic syndrome [46, 132]. 
During the first two weeks of SRT, intensity should be kept to an adaptive level so that patients 
learn the exercise techniques and their muscle mass would probably not increase. From the third week, 
the objective of the training is hypertrophy [159]. Participants should start with three sets per muscle 
group per week, on 3 non-consecutive days of the week. One set should consist of 10–15 repetitions 
corresponding with 60-70% one repetition maximum lifting weight per 2-3 sessions per week, are likely 
to be beneficial for maximizing the health effects of increased skeletal muscle mass [155]. The number of 
training sets for each muscle per week should be increased progressively every four weeks by one set to a 
maximum of 10 sets per week. The SRT program should consist of exercises for all major muscle groups 
[132, 142]. 
 
2.3 Pharmacological treatments 
  If the goal of weight loss has not been achieved after six months of good adherence to a therapy 
combining diet and physical activity, prescribing a drug treatment can be considered, always with some 
limitations and considerations [45]. 
  Regarding the pharmacological therapy, one may mention the appetite suppressants, the food 
absorption/digestion blockers and the stimulators of thermogenesis [16, 82]. There is a long list of 
prospective drugs, including tesofensine and agonists and antagonists of satiety-inducing peptides and 
orexigens respectively, confirming a potential bright future for the treatment of the pandemic of obesity 
[119]. Nevertheless, they all entail well-known adverse effects and some of them show a very doubtful 
benefit/risk rate. Some other non-pharmacological alternative products or plants have been considered, 
but none of them has proved a long-term efficacy and/or safety [42, 107]. Indeed, in Europe the only 
accepted pharmacological treatment is the prescription of Orlistat, an inhibitor of lipase, combined with a 
low-fat diet [119]. 
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2.4 Bariatric surgery  
At last, surgery may be an effective long-term treatment of morbid obesity, by reducing some 
clinical manifestations associated with obesity [88]. This approach could be indicated in subjects with 
BMI >40 kg/m2 or BMI >35 kg/m2 in the presence of comorbidities or with an inadequate metabolic 
control [117]. Diabetes is the fastest comorbidity corrected after bariatric surgery, achieving significant 
improvements in glycaemic control or eradication of the disease between 80-95% in 10 years [23, 37]. 
This surgery entails serious postoperative complications directly related with the severity of the obesity; 
also male gender and increasing age were globally associated with an increased risk of complications 
[140]. 
 
3. Hypoxic therapy and its applications 
One of the alternatives to address high prevalence diseases seems to be hypoxic therapy; which 
is commonly used in medical practice nowadays and well positioned in the field of traditional/alternative 
medicine, hypoxitherapy. The question remains open whether hypoxia or re-oxygenation is the 
responsible for the formation of adaptive signals and what the functional significance is. Experimental 
studies have not been appropriately focused on pheno-and genotypic features of the body response to 
hypoxia. Until now, what it is known is that appetite is suppressed, and a percentage of body mass is lost 
at high altitudes [126, 156]. Furthermore, oxygen variations in the organic system produce changes in 
body composition [111]. These findings can be of great interest for the treatment of obesity. Therefore, 
this review will focus on methods of hypoxia and their potential applications. 
 
3.1 Methods of hypoxic exposure and of hypoxic training 
In general, there are two types of hypoxia stimuli: 1) Intermittent hypoxic exposure (IHE): 
passive exposure to hypoxia lasting from a few minutes to hours that is usually repeated over several 
days. These intermittent hypoxic exposures are interspersed with exposure to normoxia or lower levels of 
hypoxia. IHE raises the question of the minimum duration of exposure to induce erythropoiesis. It has 
been suggested that 180 min of IHE daily are necessary to increase endogenous erythropoietin (EPO), but 
in the vast majority of protocols this appears to be inconsistent [19, 40, 75, 148]. Cerebral oxygenation 
decreases, whereas muscle oxygenation increases due to a greater ability to extract O2 in order to 
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counteract reduced O2 availability, as shown by a decreased deoxyhaemoglobin during heavy exercise 
[92], 2) Intermittent hypoxic training (IHT) consists of physical activity under hypoxic conditions (for 
short periods, and remaining at normoxic conditions for the rest of the time. This is another way to benefit 
from hypoxic stimulus without undergoing the detrimental effects of a prolonged exposure to hypoxia. 
This method induces specific molecular adaptations at muscular level that do not occur in normoxic 
conditions [116, 148].  
Several methods of IHE and/ or IHT are currently performed by elite athletes: traditional “live 
high-train high” (LHTH), “live low-train high” (LLTH), “live high-train low” (LHTL) or by using 
supplemental O2 when training in altitude (LH + TLO2) [148]. More recently, the interest of intermittent 
hypoxic methods has been investigated: IHE and IHT. The technological development of various hypoxic 
devices has also made possible to combine these methods [143]. 
In spite of the substantial differences between these forms of hypoxic training and/ or exposure, 
all these methods have the same goal, inducing physiological adaptations and enhancement of athletic 
performance [158] (Table 1). 
The experimentally used strategies differ greatly in cycle length, the number of hypoxic episodes 
per day, and the number of exposured days. Thus, protocols vary from those that examine the effect of as 
few as 3–12 relatively short (2–10 min) bouts of hypoxia interspersed with 2 to 20 min episodes of 
normoxia on a single day [15], to those that examine longer daily exposures (1–12 h) over periods 
ranging from 2 to 90 days [19, 143], and those that consider short sinusoidal cycles of hypoxia/ normoxia 
(30–90 s) 7–8 h daily for 30–70 days [75]. Regardless of the schedule, the compelling outcome is that 
these repeated episodes of hypoxia elicit persistent changes in a variety of physiological responses [27, 
58, 92, 122, 124].  
 
3.2 Intermittent hypoxia and applications in health, physiological and pathophysiological states 
Certainly, there are adaptations to chronic hypoxia that are not necessarily beneficial. Chronic 
intermittent hypoxia significantly increases right ventricular heart mass [25], it has been occasionally 
associated with pulmonary vascular remodelling and with pulmonary hypertension [96]. A number of 
investigations and trials identified physiological effects on different cells, tissues and systems and 
respiratory disorders (Table 2). 
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3.3 Intermittent Hypoxic Exposure (IHE) 
A significant percentage of the obese population suffers from obstructive sleep apnea (OSA) 
[94]. OSA is characterized by transient periods of oxygen desaturation followed by re-oxygenation, and is 
a major cause of systemic damage (oxidative stress, inflammation, sympathetic activity, vasculature 
remodelling and endothelial dysfunction) and/or protective (preconditioning-like cardioprotective) 
effects. This condition (OSA) has rarely been given importance in obese patients, although many OSA 
bearing subjects are obese, and obesity is an independent risk factor for many comorbidities associated 
with OSA [104].Thus, it has been speculated that the chronic intermittent hypoxia caused by OSA in 
obese patients might be one of the underlying mechanisms in the morbi-mortality paradox of obesity. 
Moreover, OSA increased plasma neuropeptide Y levels, an appetite-stimulating peptide, independently 
of body weight [136]. This is a controversial feature since risks concerning endocrine health caused by 
sleep breathing disorders threaten to exacerbate the already compromised metabolic regulation and 
control of normal body weight in this obese population [102]. Experimental evidence from human models 
is required to elucidate such risks and to facilitate clinical decisions about whom to treat. 
Interestingly, IHE induces lessening of bronchial spasm, more uniform lung ventilation and 
increases ventilation sensitivity to hypoxia [9]. 
Watson et al [152] explored genetic contributions of sleep disturbances in over 1800 twin pairs 
and found that 10% of common additive gene effects accounted for 10% of the phenotypic association 
between obesity and insomnia. Similar gene model fitting studies are needed to assess the genetic 
contribution of reduced sleep to BMI [94]. 
Sleep intermittent hypoxia debt exerts profound effects on metabolic hormones and molecular 
signatures [4]. These changes are accompanied by an increased food intake and energy storage, which 
potentiates the development of insulin resistance, T2D, hypertension and heart disease [113]. Recent 
reports provide new insights about possible mechanisms to explain OSA effects on lipid and glucose 
metabolism by inducing sympathetic activation, increasing systemic inflammation, stimulating counter-
regulatory hormones and fatty acids, or causing direct pancreatic beta-cell injury [44].  
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Lately, it has been shown that hypoxia through factor HIF-1 expression changes, helps to 
regulate mitochondrial function. It is interesting to note that there are often defects in the mitochondrial 
function in many pathophysiological processes, which seem to improve with the stimuli of IHE [130].  
 
3.4 Intermittent Hypoxic Training (IHT) 
The potential applications of IHT in health and in various pathophysiological states are 
numerous [9, 76], since it could be a non-pharmacological method for enhancing some physiological 
functions and rehabilitation in patients with different chronic diseases [63]. Hypoxic training increased 
physical work capacity about 5% in the healthy elderly subjects and 10% in elderly subjects [155].  
The ventilatory response to hypoxia increases during submaximal exercise, and induces a smaller 
hypoxic pre-acclimation decrease in arterial oxygen saturation (SpO2) [54, 110]. Furthermore, IHT has 
been shown to raise baroreflex sensitivity to normal levels and to selectively increase hypercapnic 
ventilatory response, total exercise time, total haemoglobin blood levels, and lung diffusion capacity for 
carbon monoxide in bronchial asthma and chronic obstructive pulmonary disease patients [149]. 
Some favourable effects of IHT are conditioned by triggering a long-term adaptation to hypoxia, 
leading to positive changes in internal organs. These phenomena have been well studied in young and 
middle aged people. In the cardiovascular systems, reduced sympathetic-adrenal reaction to stress and the 
blood flow along vessels of miocirculatory system was improved at the expense of increases on the 
diameter of arterioles [63]. In elderly people IHT, had a positive influence on the antioxidant system, 
along with an activation of the antiradical defence enzymes, and a decrease of lipid peroxidation products 
in tissues [18].  
  A few studies have investigated the influence of various IHT regimens on inflammation-related 
cytokine secretion caused by acute exercise [151]. Severe IH or moderate IH (12-15% O2, 1 hour/ day, 5 
days/week for 8 weeks) ameliorated the effects of severe exercise on IL-1β secretion. A possible reason 
for this outcome is that training increases circulatory anti-inflammatory cytokine levels, such as IL-6 and 
IL-10, with inhibited production of IL-1β during severe exercise [150]. 
The neuroprotective role of EPO has been proven [129] by showing that normobaric hypoxia 
reduced the risk of cardiovascular disease [99, 155 164], improved the respiratory function [68], produced 
CNS protection [89] and basal metabolism reprogramming [7]. On the other hand, it is known that 
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training in hypoxia and in normoxia reduced the circulating concentration of free fatty acids, total 
cholesterol and HDL cholesterol. However, it did not reduce the levels of homocysteine, an acidic 
molecule implicated in heart disease [98].  
At the same time, it has been demonstrated that IHT may normalize blood pressure in 
hypertensive patients [123, 124]. Moreover, it has been shown that systolic blood pressure is reduced 
after IHT, causing a hypotensive effect [43]. Thus, it has been confirmed that physical exercise in hypoxia 
decreases the risk of cardiovascular disease [12, 24].  
  On the other hand, aging is associated with changes in breathing regulation, particularly, in 
respiratory sensitivity to IHT. One theory of aging holds that reactive oxygen species play a key role in 
this process. These species have also been implicated in the carotid body O2 sensing. Studies have 
investigated hypoxic ventilatory responses (HVR) and antioxidant enzymes activity in healthy young and 
elderly people in adaptation to IHT [76]. The elderly demonstrated decreased HVR and blood catalase 
(CAT) activity on a background of strong negative correlation between the levels of end-tidal CO2 tension 
and superoxide dismutase (SOD) activity. The adaptation to IHT resulted in increased HVR and SOD 
activity in both groups [76]. 
Furthermore, results of clinical studies have shown that IHT in elderly patients could be useful 
and valuable, leading to reduction in clinical symptoms of angina and duration of daily myocardial 
ischemia, normalization of lipid metabolism, optimization of oxygen consumption, improvement of 
vasomotor endothelial function due to increased formation of nitric oxide, normalization of 
microcirculation and increased exercise tolerance [77, 78].  
 
3.5 Intermittent hypoxia and insulin sensitivity 
Acclimation to an altitude of 4000m in IHE has been found to decline blood glucose, parallel to 
a higher glucose turnover, both at rest and during exercise [21]. This increased muscle uptake of glucose 
is accompanied by enhanced insulin sensitivity [11, 131]. Likewise, it was reported that, in high altitude 
(2600m) the HbA1c decreased significantly in obese people four weeks after the altitude stay [84]. 
An increase in body fat is linked with a decline in insulin sensitivity in both obese and elderly 
individuals, and a recent study showed that acute hypoxic training improved glucose tolerance, and that 
combined exercise in hypoxic state further ameliorated insulin sensitivity in T2D [87]. Other trial 
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demonstrated that IHE glucose tolerance enhancement four hours after exposure can be attributed to 
improvements in peripheral insulin sensitivity in sedentary males with T2D. Therefore, it may improve 
short-term glycaemic control [85].  
Similar to the effects of exercise, increased epinephrine during IHE, which was reported in 
healthy humans may have contributed to glycogen utilization via increases in cyclic adenosine 
monophosphate concentrations, potentially leading to post-treatment increased on insulin sensitivity [72]. 
Similarly, it has been described that both IHE and IHT programmes carried out in hypoxic conditions 
increased glucose transporter GLUT-4 levels [33].  
Hypoxia and exercise have shown an additive effect on insulin sensitivity [87], suggesting that 
insulin signalling and insulin-dependent glucose transport, might have been up-regulated following 
hypoxic exercise [33, 34]. This additive improvement could also be attributed to an increase in the 
relative intensity of the practised exercise in hypoxia [56]. To sum up, acute hypoxic exercise could 
improve short-term glycaemic control in sedentary individuals with insulin resistance. 
 
3.6 Intermittent hypoxia training and molecular mechanisms 
In recent years, certain proteins involved in the process of sensing and regulating the 
concentrations of oxygen in tissues have been described. Such proteins may have a predominant role in 
the hypoxia inducible factor (HIF) and in the hydroxylase regulation [92]. 
There is a large demand of oxygen during physical activity, regardless the type and intensity of 
exercise [73]. In spite of that, there is a general condition of ischemia-reperfusion due to the high voltage 
generated by the muscles during maximal or submaximal contractions. In other words, there are cycles of 
hypoxia-hyperoxia [35]. Physical activity leads to an increase in oxygen free radicals, but it is not entirely 
clear whether the phenomenon linked to free radicals increase is hypoxia or hyperoxia. However, it seems 
that hyperoxia is the most likely factor [157]. Other researchers have suggested that free radicals are 
possible mediators of the response to hypoxia [3]. However, it has not been possible to fully understand 
the interaction between hypoxia-hyperoxia, free radicals, HIF and intracellular signalling, neither in the 
skeletal muscle, nor in other cells yet [157]. 
  There are reports showing that after six weeks of physical training, mRNA levels of HIF-1 rise 
(between 58-82%) only in subjects who trained in hypoxic environment (3850m), both at low and at high 
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intensity, compared to other groups who trained in normoxia at low and high intensities of exercise [58, 
148]. These studies suggest that there are no HIF-1 increases in normoxic environments and that in 
hypoxia only the effects achieved due to physical training in normoxia are relevant. 
  On the other hand, mRNA levels of phosphofructokinase gene, a key enzyme in glycolysis, are 
increased as it has been shown to occur only in high-intensity IHT [148]. This finding that the intensity of 
exercise in hypoxia may have different effects at the metabolic level, and that might be related to 
variations between the hypoxia and the hyperoxia produced, required to be further clarified. 
There is an extensive list of genes regulated by hypoxia [122], many of which are involved in 
growth and differentiation [153]. Furthermore, it is also known that exercise regulates the expression of 
many genes, but the mechanisms are often unknown and the genes controlling this phenomenon (and 
favour cardiovascular health) are still under investigation. Regular bouts of physical activity may cause 
changes in gene expression that accumulate over time and, ultimately, affect phenotypes, such as body 
weight, blood lipid profile and tumour development. Furthermore, acute activity may affect gene 
expression and phenotypes differently depending on whether the individual is regularly inactive or active 
[128]. Knowledge of these genes would help to understand, for example, how exercise leads to muscle 
hypertrophy. This outcome suggests that further studies are needed to evaluate the relationship between 
hypoxia and the genes regulated by the HIF-1.  
  Adaptations to exercise or hypoxia are increasingly being applied preventively or as a treatment 
to different pathophysiological situations and, therefore, they begin to have global significance [27]. HIF 
expression is upregulated with exercise and it might be an important factor that regulates adaptive gene 
responses to exercise [86]. It is therefore, important that only high-intensity training under hypoxic 
conditions leads to adaptations that include regulation and elevated HIF-1, as a mechanism to compensate 
the reduced availability of oxygen. It seems that intense muscle contraction and oxygen deficiency are 
essential to generate some adjustments. Thus, it has been noted that the muscle generates a series of major 
adaptations when training in hypoxia [58].  
  However, at the present time there is scarce information about how different intensities and 
kinetic contraction of muscle affect activation of HIF-1 and other proteins [58]. The only available 
information is that HIF-1 average life is less than five minutes [55]. For this reason, training protocols in 
intermittent hypoxia are usually of 5’-5’, hypoxia-normoxia. This situation may explain why training at 
sea level is not enough to alter the HIF-1 cascade [86]. Although it may be surprising, the studies 
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developed by Lundby and his colleagues indicate that regular training reduces the hypoxia observed after 
acute exercise. Therefore, there are no major changes in the HIF-1, as they existed at the beginning of 
the training [100]. Although cellular hypoxia persists, the HIF-1 is not affected equally and, as a 
consequence, it becomes tolerant to hypoxia. According to Lundby and colleagues (2006), there are other 
mechanisms explaining the effects produced by intermittent chronic training in hypoxia. Nitric oxide (a 
potent vasodilator) may be involved in this adaptive mechanism, but no studies proving this hypothesis 
have been found. Oxygen free radicals may be the other factor involved in this mechanism [29], since it is 
known that they increase in hypoxia and that, at the same time, they are mediators of muscular 
adaptations [57, 58, 64]. 
 
3.7 Intermittent hypoxia and exercise: possible applications in obesity 
Oxygen plays an important role, as electron acceptor in the long chain of reactions produced to 
obtain energy in the form of ATP, both in humans and in other higher organisms. Low oxygen levels lead 
to tissue hypoxia; high oxygen levels lead to inflammation hyperoxia [140]. The two states entail 
different effects, and body composition changes may occur because of them [111]. Studies show that 
appetite is suppressed and that there is body mass loss at high altitudes [126, 156]. Similarly, it has been 
noted that oxygen variations in the organic system produces changes in body composition [111].  
  Acute exposure to hypoxia, both in humans and in rats, produces an increase in blood serotonin 
levels [51]. Moreover, hypoxia causes an increase in the adrenergic system [6, 159]. Food intake, protein 
intake and carbohydrates selection, as well as body weight, are partially regulated by serotonin, a 
compound that after administration to rats produces anorexia [51].  
Rats submitted to a high altitude (Cerro de Pasco, Perú, 4340 m) for up to 84 days showed a 
physiological adaptive response with decreased body weight gain (-15%), increased right ventricle weight 
(+100%), and increased hematocrit (+40%) compared with sea level animals. These classical parameters 
of adaptation to high altitude were accompanied by an increase in heart mitochondrial enzymes: 
complexes I-III activity by 34% and mitochondrial nitric oxide synthase (mtNOS) activity and expression 
by more than 75% [160]. 
Similarly, in obese subjects it is known that leptin is involved in regulating body weight and 
controlling energy resources [12, 139]. It has been observed that acute hypoxia decreases blood glucose 
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and basal leptin levels [72]. These observations allow us to consider the hypothesis that IHE defined as 
situations of exposure to low concentrations of ambient oxygen alternating with periods of normoxia [61] 
may result in decreased appetite and fat loss, which might be of interest for the treatment of obesity. On 
the other hand, IHE can reduce not only body weight by increasing leptin concentration and enhancing 
liver leptin expression, but also decrease serum glucose, blood cholesterol and meanwhile prevent 
steatosis in liver cells effectively, in obese mice [83]. Moreover, it has been described that obese 
individuals staying one week at 2650m of altitude (without exercise) lost weight and reduced blood 
pressure [84]. It can be hypothesized that adding exercise to the IHE stimulus could result in further 
cardiovascular changes and in an improved health and body composition. 
Physical activity in hypoxia increased the number of mitochondria, the capillary density [107], 
and muscle oxidative enzymes, and changed energy production pathways with potential for an increase in 
lipolysis [116]. Adaptive responses to the respiratory tract and cardiovascular system are produced and, at 
the same time, the mitochondrial efficiency, pH / lactate regulation [81, 164], and physical performance 
are increased [17, 108, 143].  
  There is scientific evidence suggesting that a lower degradation of hypoxia inducible-factor 
alpha (HIF-1 factor ) caused by conditions of hypoxia, along with physical activity, can prove very 
effective and be part of major medical applications in the long-term [27]. After 6-week training in IH, 
there was a dramatic increase in mRNA concentrations of many genes, such as HIF-1 (+104%), glucose 
transporter-4 (+32%), phosphofructokinase (+32%), citrate synthase (+28%), carbonic anhydrase-3 
(+74%) or monocarboxylate transporter-1 (+44%) [148]. These results demonstrated that training in IH at 
high intensity is probably a good way to favour oxygen utilization within the muscle. 
Thus, the hypoxic stimulus in addition to diet and exercise can be another powerful incentive to 
lose weight, which may have effects in the mid-long term (unlike diet therapy and physical activity 
alone), since effects of hypoxia are maintained for one month post-treatment, due to increases in basal 
noradrenalin and other possible changes that remain to be clarified [84].  
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Proposed new hypoxic training model 
The Intervalic Hypoxic Training protocol comprises repeated exposures to hypoxic air breathing, 
altered witch breathing environment (normoxic) air. During the training course, strength-resistance 
exercises (20´) and high intensity aerobic exercises (30-40´) are performed. The hypoxic air decreases 
gradually from 16,7-11,2% (SpO2, 89-75%) in order to provide a step-wise adaptation and to avoid over-
training. Sesions are repeated 3-4 times per week for periods of 3-6 weeks, and session duration is in the 
range of 40-60´ (Table 3).  
The physiological response is monitored by a pulsioxymeter, a device that measures SpO2 and 
heart rate (HR). Other physiological parameters can also be monitored, for instance blood pressure and 
cardiac activity by an electrocardiogram. Monitoring of the user’s physiological parameters allows us to 
avoid the undesirable effects of over-dosing. Advanced bio-feedback controlled hypoxicators are capable 
of adjusting the oxygen concentration in the inhaled hypoxic air automatically, compensating for 
individual variability [15, 143]. 
Hypoxia Stimulus charge (HSc= SpO2% x time in minutes) parameter provides an objective 
measure of the hypoxic stress delivered during the IHT session, compared to simple recording of the 
inhaled fraction of oxygen (FiO2). HSc provides the dosage received by a person at the end of the session 
and compensates for individual variability in scientific studies, to ensure that subjects are correctly 
controlled for individual exposure. It is accepted that tissue hypoxia develops only when SpO2 drops to 
90% or below. This is due to the oxyhaemoglobin dissociation curve. SpO2 above 90% produce very 
little effects or decrease of arterial partial pressure (PaO2). Due to all these data, our protocol of IHT 
comprises ranges of SpO2 between 75 and 89%. 
 
Concluding remarks  
High intensity exercise and intermittent hypoxia in the short and long term may have important 
medical applications in pathophysiological problems with metabolic-muscular disorders, such as 
obesity. However, nowadays there are few studies and clinical initiatives to use stimuli of intense physical 
activity or intermittent hypoxia, with the uncertainty that patients may not bear this type of training or that 
the training may not result very pleasant for them. Although it is not possible to stay at high altitude and 
to remain there in many countries - due to orographic conditions-, current technology allows to simulate 
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the effects of altitude (hypoxia) at sea level, through instruments that reduce the content of oxygen on 
inspired air (normobaric hypoxia) (Figure 1).  
  Intermittent hypoxia may have many applications for improving cardiovascular health, the great 
public health concern in Western societies [24]. Similarly, stays in altitude or hypoxic situations may help 
to lose weight and normalize arterial blood pressure. Summing up, the IHT is a non-pharmacological 
method, for enhancing the functional resources of a healthy organism and the rehabilitation in patients 
with different chronic diseases. The IHT stimulus could be of great tool and very practical for clinical use 
in obese patients by reducing appetite and regulating fat deposition. 
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Table 1. Different methods of hypoxic exposure and of hypoxic training 
 
 
Methods of 
Hypoxic Exposure  
and/ or Training 
Hypoxic exposure, passive (IHE) Hypoxic training, active (IHT) 
IHE + normoxia LL-TH 
IHE + supplemental O2 IHIT 
LHTL: 
Hypoxic generation method: 1) natural 
altitude (IH), 2) nitrogen dilution (NH), 
3) Oxygen filtration (NH) 
AHCT 
LHTH (IHE+IHT) 
 
Examples 1) 5 - 5´ environment air (FiO2 = 
20,5%) - hypoxic air-gas (FiO2= 9-
12%)/ 60-180´ per day/ 2-4 weeks [15, 
68] 
2) 8-12 h to sleep (FiO2 = 11,2-15,6%) 
per day/ 3- weeks [15, 158] 
1) 90-120´ environment air (FiO2 = 16,7-
14,6%) [108] or altitude (2000-3000m) 
low-moderate intensity/ 4-5 
sessions/week/ 3-8 weeks [17] 
2) 30-60´ambient air (FiO2 = 16,7-
11,2%) [57, 100, 143] or altitude (2000-
5000m) high intensity exercise/ 2-4 
sessions week/ 3-6 weeks [19, 75] 
Usefulness Pre-acclimation in climbers [17] 
Heart [24], respiratory [9,68, 69, ] and 
nervous [129, 161, 162] diseases 
Health field in general [15, 55, 60 123] 
Performed by athletes [17, 19, 57, 75 81, 
108, 116, 143, 158, 163]  
Pre-acclimation in climbers [54] 
Metabolic and cardiovascular risk [12, 
24, 29, 43, 63, 77, 162] 
Glycaemic control [13, 33] 
Antioxidant system [18, 147] 
NH: Normobaric Hypoxia; HH: Hypobaric hypoxia; LH: Living High; TH: Training High; TL: Training 
Low; LHTL: Living High Training Low; LHTH: Living High Training High; LL: Living Low; IHE: 
Intermittent Hypoxic Exposure; IHT: Intermittent Hypoxic Training; IHIT: Intermittent Hypoxic Interval-
Training; AHCT: Altitude-Hypoxic Continue Training. 
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Table 2: Compensatory mechanisms and responses to hypoxia 
Respiratory  
system 
Cardiovascular 
system 
Cellular and metabolic Regulation of  
body weight 
Hiperventilation [155] Increases basal and 
maximal heart rate  
[6, 52] 
HIF-1 factor and VEGF 
expression  
[122, 153] 
Decreases basal leptin 
levels [72] 
Increases lung 
diffusion capacity for 
CO and O2 [149] 
Increases peripheral 
vasodilation [63] 
 
Angiogenesis 
 [28, 47] 
Increases adrenergic 
system  
[85, 159] 
Increases the CO2 
reserve in sleeping [69] 
Increases diameter of 
arterioles  
[63] 
Increases glycolytic 
enzymes and number of 
mitochondria 
[46] 
Basal noradrenaline 
remains high post 
treatment  
[84] 
Decrease in SaO2 was 
smaller [110] 
Increases Hg-O2 
affinity 
 [32] 
O2, Fe and glucose 
conveyors [109] 
Increases blood 
serotonin levels [51] 
Ventilatory response 
during exercise  
increased [54] 
Normalises blood 
pressure [12, 124] 
 
Improves insulin 
sensitivity [87] 
Appetite is suppressed  
[126, 156] 
Improves respiratory 
function [68] 
Cardiovascular 
protection [155, 163] 
 
Increases glucose 
transporter GLUT-4 [33, 
34] 
Increases body weight 
loss [84] 
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Table 3. New method of IHT (proposed by the authors of this review) 
Method 40-60´environment air (FiO2 = 16,7-11,2%) or altitude (2000-
5000m) / sets of strength-resistance exercises (20´) + high 
intensity aerobic exercise (30-40´) /3-4 sessions week/ 4-6 weeks 
Sets and recovery times Exercise between sets: 20´´-180´´ 
Recovery between sets: 2-6´ 
Target SpO2% Exercise between sets: 75-80% 
Recovery between sets: 80-89% 
Hypoxia Stimulus charge 
(HSc) 
HSc= SpO2% x t (time in minutes) 
3400-4800 units 
Total sessions 16-24 
Applications High prevalence diseases: 
Obesity  
Hypertensive patients  
DT2 
OSA 
Sports: 
Elite athletes (sport specific 
exercises) 
Pre- acclimation in climbers 
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Figure 1. Normobaric-Hypoxic tent equipped for research [143] and used to trained climbers for an 
Everest expedition, 2011 (unpublished results). 
 
